Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink

December 15, 2022Posted inCPRD, Drug Safety Studies, Recent student studies conducted at BCDSP, Safety of other important drugs, Student Studies
Journal: European Heart Journal of Cardiovascular Pharmacotherapy Authors: Brenda N Baak, Susan S Jick NLM Citation: Baak BN, Jick SS. Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use…

Proton-pump inhibitor use and myocardial infarction: a nested case-control study in the UK Clinical Practice Research Datalink

May 31, 2020Posted inDrug Safety Studies, Recent student studies conducted at BCDSP, Safety of other important drugs, Select Publications, Student Studies
Journal: Epidemiology (Cambridge, MA) Authors: Yiran Qian, Susan Jick NLM Citation: Qian Y, Jick S. Proton-pump inhibitor use and myocardial infarction: a nested case-control study in the UK Clinical Practice Research…

The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database

March 25, 2020Posted inDrug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications
Journal: Journal of the American Academy of Dermatology Authors: Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick NLM Citation: Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risk…

The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database

February 28, 2020Posted inDrug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications
Journal: Journal of the European Academy of Dermatology and Venereology Authors: C Vasilakis-Scaramozza, R Persson, K W Hagberg, S Jick NLM Citation: Vasilakis-Scaramozza C, Persson R, Hagberg KW, Jick S. The risk of…

Herpes zoster, hepatitis C, and tuberculosis risk with apremilast compared to biologics, DMARDs and corticosteroids to treat psoriasis and psoriatic arthritis

February 12, 2020Posted inDrug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications
Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Rebecca Persson, Catherine Vasilakis-Scaramozza, Steve Niemcryk, Michael Peng, Maria Paris, Anders Lindholm, Susan Jick NLM Citation: Hagberg KW, Persson R, Vasilakis-Scaramozza C, Niemcryk S, Peng M, Paris M, Lindholm A,…

Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids

March 18, 2019Posted inDrug Safety Studies, Safety of other important drugs, Select Publications
Journal: British Journal of Clinical Pharmacology Authors: Rebecca Persson, Susan Jick NLM Citation: Persson R, Jick S. Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the…

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

November 1, 2018Posted inDevelopmental Disabilities, Drug Safety Studies, Mental Health, Other important conditions, Safety of drugs in pregnancy, Select Publications
Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Annelies L Robijn, Susan Jick NLM Citation: Hagberg KW, Robijn AL, Jick S. Maternal depression and antidepressant use during pregnancy and the risk of autism…